drugset / Trial / NCT05319756
Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users
RandomizedCrossoverQuadruple-blindOther
Summary
This will be a randomized, double-blind, double-dummy, placebo- and active-controlled, 6 treatment, 6-period crossover single-dose, Williams square design study in healthy male and/or female adult, non-drug-dependent recreational opioid users.
Timeline
- Start
- 2021-04-30
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | 600 mg | Oral |
| Subject | Gabapentin | Small molecule | 1200 mg | Oral |
| Comparator | Oxycodone | Other / unclassified | 20 mg | Oral |